You know that pharma is joining the health-reform effort this time around, probably because company execs know they can't beat it completely. And you know that they're using that seat at the table to promote changes that they consider pharma-friendly. For lots more on drugmakers' offense-is-the-best-defense approach, check out the Wall Street Journal analysis. Report